BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8678422)

  • 21. Antibody processing and engineering in plants, and new strategies for vaccine production.
    Ma JK; Drake PM; Chargelegue D; Obregon P; Prada A
    Vaccine; 2005 Mar; 23(15):1814-8. PubMed ID: 15734047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of plant expression systems in antibody production for passive immunization.
    Virdi V; Depicker A
    Int J Dev Biol; 2013; 57(6-8):587-93. PubMed ID: 24166441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Antibody Fragments for Neurodegenerative Diseases.
    Manoutcharian K; Perez-Garmendia R; Gevorkian G
    Curr Neuropharmacol; 2017; 15(5):779-788. PubMed ID: 27697033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of antibody fragments in Escherichia coli.
    Harrison JS; Keshavarz-Moore E
    Ann N Y Acad Sci; 1996 May; 782():143-58. PubMed ID: 8659891
    [No Abstract]   [Full Text] [Related]  

  • 25. [Site-specific expression of single-stranded antibody fragments in Nicotiana tabacum].
    Morgun BV; Deshmuk S; Stepaniuk V; Pasternak T; Lukach N
    Tsitol Genet; 2005; 39(3):43-9. PubMed ID: 16250245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
    Weisser NE; Hall JC
    Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case for plant-made veterinary immunotherapeutics.
    Topp E; Irwin R; McAllister T; Lessard M; Joensuu JJ; Kolotilin I; Conrad U; Stöger E; Mor T; Warzecha H; Hall JC; McLean MD; Cox E; Devriendt B; Potter A; Depicker A; Virdi V; Holbrook L; Doshi K; Dussault M; Friendship R; Yarosh O; Yoo HS; MacDonald J; Menassa R
    Biotechnol Adv; 2016; 34(5):597-604. PubMed ID: 26875776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plant-made pharmaceuticals].
    Faye L; Lerouge P; Gomord V
    Ann Pharm Fr; 2003 Mar; 61(2):109-18. PubMed ID: 12668949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody produced by using Escherichia coli expression systems.
    Shibui T; Nagahari K
    Bioprocess Technol; 1994; 19():253-68. PubMed ID: 7764761
    [No Abstract]   [Full Text] [Related]  

  • 32. Affinity of recombinant antibody and antibody fragment binding to human thyroglobulin: potential applications in gene therapy.
    Mani JC; Noel D; Marin M; Navarro-Teulon I; Biard-Piechaczyk M; Pau B; Piechaczyk M
    J Mol Recognit; 1998; 11(1-6):117-8. PubMed ID: 10076821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody production in plants.
    Smith MD
    Biotechnol Adv; 1996; 14(3):267-81. PubMed ID: 14537156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering novel antibody molecules.
    Sensel MG; Coloma MJ; Harvill ET; Shin SU; Smith RI; Morrison SL
    Chem Immunol; 1997; 65():129-58. PubMed ID: 9018876
    [No Abstract]   [Full Text] [Related]  

  • 35. Design and production of multimeric antibody fragments, focused on diabodies with enhanced clinical efficacy.
    Powers GA; Hudson PJ; Wheatcroft MP
    Methods Mol Biol; 2012; 907():699-712. PubMed ID: 22907381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality assessment of recombinant proteins produced in plants.
    Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL
    Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants.
    Rodríguez M; Pérez L; Gavilondo JV; Garrido G; Bequet-Romero M; Hernández I; Huerta V; Cabrera G; Pérez M; Ramos O; Leyva R; León M; Ramos PL; Triguero A; Hernández A; Sánchez B; Ayala M; Soto J; González E; Mendoza O; Tiel K; Pujol M
    Plant Biotechnol J; 2013 Jan; 11(1):53-65. PubMed ID: 23046448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-based metabolic engineering in plants.
    Nölke G; Fischer R; Schillberg S
    J Biotechnol; 2006 Jun; 124(1):271-83. PubMed ID: 16698105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plant-based production of recombinant cytokines].
    Góra-Sochacka A; Redkiewicz P; Napiórkowska B; Sirko A
    Postepy Biochem; 2009; 55(1):85-94. PubMed ID: 19514469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.